|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficaey and safety of the low-molecular weight heparin enoxaparin compared with unfraetionated heparin across the acute coronary syndrome spectrum : a meta-analysis显示文摘 | Murphy SA Gibson CM Morrow DA | 2007 | Eur Heart J2007，28，17： | 1 |
| 2 | Efficacy and safety ofthe low-molecular weight heparin enoxaparin compared withunfractionated heparin across the acute coronary syndromespectrum: a meta-analysis 显示文摘 | Murphy SA Gibson CM Morrow DA | 2007 | Eur Heart J2007，28，17： | 1 |
| 3 | A randomized trial to evaluate the relative protection against post- percntaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial 显示文摘 | Gibson CM Morrow DA Murphy SA TIMI Study Group | 2006 | J Am Coil Cardiol2006，47，： | 1 |
| 4 | Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis in Myocardial Infarction study 25 (ExTRACT TIMI 25) trial显示文摘 | Morrow DA Antman EM Murphy SA | 2007 | Am Heart J2007，154，6： | 1 |
| 5 | Angiographic perfusionscore: an angiographic variable that integrates both epicardial andtissue level perfusion before and after facilitated percutaneouscoronary intervention in acute myocardial infarction显示文摘 | Gibson CM Murphy SA Morrow DA | 2004 | Am Heart J2004，148，2： | 1 |
| 6 | G( 1 ) Phase growth arrest and in- duction of P21 (Wafl/Cipl/Sdil) in IB3 - 1 cells treated with 4 - so- dium phenylbutyrate 显示文摘 | McGrath - Morrow SA Stahl JL | 2000 | J Pharmacol Exp Ther2000，294，3： | 1 |
| 7 | Does aggressive lo- cal therapy improve survival in metastatic breast cancer? 显示文摘 | Khan SA Stewart AK Morrow M | 2002 | Surgery2002，132，4： | 1 |
| 8 | A randomized,placebo-controlled trial to evaluate the tolerability,safety,pharmacokinetics,and pharmacodynamics of a potent inhibitor of poly (ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percuta显示文摘 | Morrow DA Brickman CM Murphy SA | | 0，，04： | 1 |
| 9 | Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum:a meta-analysis显示文摘 | Murphy SA Gibson CM Morrow DA | 2008 | Euro Heart J2008，28，17： | 1 |
| 10 | Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction 显示文摘 | Gibson CM Murphy SA Morrow DA | 2004 | Am Heart J2004，148，： | 1 |
| 11 | The cutaneous angioma of Sturge-Weber syndrome显示文摘 | Morrow SA Campbell C | 2008 | Can J Neurol Sci2008，35，： | 1 |
| 12 | Association among plasma levels of monocyte chemoattractant protein-1,traditional cardiovascular risk factors,and subclinical atherosclerosis显示文摘 | Deo R Khera A McGuire DK Murphy SA Meo Neto Jde P Morrow DA | 2004 | J Am Coll Cardiol2004，44，： | 1 |
| 13 | A randomized, placebo-controllod trial to evaluate the tolerability, safety, phar- macokinetics, and pharmacodynamics of a potent inhibitor of poly (ADP-ribose) polymerase( INO-1001 ) in patients with ST-eleva- tion myocardial infarction undergoing primary percutaneous coronary intervention : results of the TIMI 37 trial显示文摘 | Morrow DA Brickman CM Murphy SA | 2009 | J Thromb Thrombolysis2009，27，4： | 1 |
| 14 | Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes显示文摘 | De Lemos JA Morrow DA Sabatine MS Murphy SA Gibsor CM Antman EM | 2003 | Circulation2003，107，5： | 1 |
| 15 | Vascular endothelial growth factor receptor 2 blockade disrupts postnatal lung development 显示文摘 | McGrath - Morrow SA Cho C Zhen L | 2005 | Am J Respir Cell Mol Biol2005，32，5： | 1 |
| 16 | Efficacy and safety of the low--molecular weight heparin enoxaparin compared with unfraction- ated heparln across the acute coronary syndrome spectrum:a meta--a- nalysis显示文摘 | Murphy SA Gibson CM Morrow DA | 2007 | Eur Heart J2007，28，17： | 1 |
| 17 | Does aggressive local therapy improve survival in metastatic breast cancer显示文摘 | Khan SA Stewart AK Morrow M | 2002 | Surgery2002，132，4： | 1 |
| 18 | Does aggressive local therapy improve survival in metastatic breast cancer? 显示文摘 | Khan SA Stewart AK Morrow M | 2002 | Surgery2002，132，4： | 1 |
| 19 | Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis显示文摘 | Murphy SA Gibson CM Morrow DA | 2007 | Euro Heart J2007，28，17： | 1 |
| 20 | Clinical features and outcomes of women with unstable ischemic heart disease: Observations from metabolic efficiency with ranolazine for less ischemia in non-st-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (mer- lin-timi 36) 显示文摘 | Mega JL Hochrnan JS Seirica BM Murphy SA Sloan S McCabe CH Merlini P Morrow DA | 2010 | Circulation2010，121，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员